Can-Fite BioPharma Ltd.

CANF

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0001536196

SEC filings (opens in a new tab)

No open-market purchases or sales by Can-Fite BioPharma Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $149.1K in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Can-Fite BioPharma Ltd. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of CANF: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Q3 2022	Change
Holders	12	12	0
Shares	505.7K	495.6K	−10.1K (−2.0%)
Value	$464.7K	$380.5K	−$84.3K (−18.1%)

New holders (1)

Institutions that held Can-Fite BioPharma Ltd. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to CANF in Q3 2022
Institution	Shares	Value	% of portfolio
Two Sigma Securities, LLC	14,574	$11.0K	0.00%

Sold out (1)

Institutions that held Can-Fite BioPharma Ltd. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of CANF in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Captrust Financial Advisors	1,549	$1.00K